Literature DB >> 11312664

Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection.

S P Singh1, P Tungaturthi, M Cartas, B Tomkowicz, T A Rizvi, S A Khan, V S Kalyanaraman, A Srinivasan.   

Abstract

Human immunodeficiency virus type-1 (HIV-1) Vpr is a virion-associated protein implicated to have a role in AIDS pathogenesis. In regard to the amount of Vpr incorporated into virus particles, the published data vary widely. To address this, we quantitated Vpr in virus particles derived from diverse sources that are used to evaluate the biological effect of Vpr. Virus particles from infected cells showed only a small amount of Vpr. Interestingly, virus particles from cells cotransfected with HIV-1 proviral DNA lacking Vpr coding sequences (NLDeltaVpr) and a Vpr expression plasmid showed a drastic increase (29.4-fold) in the incorporation of Vpr. Furthermore, cotransfection involving NLDeltaVpr and different concentrations of Vpr expression plasmid resulted in virus particles containing Vpr in proportion to the Vpr expression plasmid used. The differences in virus particles with respect to Vpr as revealed by these studies should be taken into account in assessing the effect of Vpr. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312664     DOI: 10.1006/viro.2001.0849

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

2.  HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.

Authors:  Joëlle V Fritz; Denis Dujardin; Julien Godet; Pascal Didier; Jan De Mey; Jean-Luc Darlix; Yves Mély; Hugues de Rocquigny
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

3.  Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy.

Authors:  Linden A Green; Ying Liu; Johnny J He
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

4.  Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages.

Authors:  Michael P Sherman; Carlos M C de Noronha; Lauren A Eckstein; Jason Hataye; Pamela Mundt; Samuel A F Williams; Jason A Neidleman; Mark A Goldsmith; Warner C Greene
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

6.  Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.

Authors:  Tanay M Desai; Mariana Marin; Chetan Sood; Jiong Shi; Fatima Nawaz; Christopher Aiken; Gregory B Melikyan
Journal:  Retrovirology       Date:  2015-10-29       Impact factor: 4.602

Review 7.  The β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion Mechanisms.

Authors:  Daniel M Jones; Sergi Padilla-Parra
Journal:  Sensors (Basel)       Date:  2016-06-23       Impact factor: 3.576

8.  Rapid formation of human immunodeficiency virus-like particles.

Authors:  Joanna Bednarska; Annegret Pelchen-Matthews; Pavel Novak; Jemima J Burden; Peter A Summers; Marina K Kuimova; Yuri Korchev; Mark Marsh; Andrew Shevchuk
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-17       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.